Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Posaconazole Oral Suspension bulk supplier for pharma manufacturers

Posaconazole Oral Suspension 40 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Oral Suspension

Available Strengths: 40 mg/mL

Reference Brands: Noxafil(US & EU)

Category: Anti-fungal

Posaconazole oral suspension inhibits fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis and fungal cell membrane integrity. It offers broad-spectrum antifungal activity, improved absorption, and versatility for prophylaxis and treatment of invasive fungal infections. Benefits include effective coverage, convenient dosing, and high bioavailability for managing severe fungal diseases.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Posaconazole oral suspension is approved in the EU and US for prophylaxis and treatment of invasive fungal infections. In the EU, MSD’s Noxafil suspension is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on comprehensive clinical data and biosimilarity assessments, with ongoing pharmacovigilance. Both regions require detailed regulatory dossiers for initial approval and continual safety monitoring. For expert support with dossiers, regulatory submissions, and compliance, visit PharmaTradz. We help ensure smooth market entry and adherence to European and American standards, enabling effective management of fungal infections with posaconazole oral suspension.

Posaconazole Oral Suspension — third party manufacturing & bulk supply

Posaconazole Oral Suspension 40 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Posaconazole Oral Suspension listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Posaconazole Oral Suspension →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Posaconazole is used to prevent and treat serious fungal infections in high-risk patients, especially those with weakened immune systems such as individuals with hematologic cancers or transplant recipients. It is effective against invasive aspergillosis, mucormycosis, and resistant Candida infections, and is often used when other antifungals are not tolerated or have failed.

Posaconazole contains the active triazole antifungal compound posaconazole. The formulation uses specific pharmaceutical excipients designed to enhance absorption in the digestive system and ensure stable systemic exposure.

The main trade name is Noxafil, widely used in the USA, EU, UK, and other international regions.

Noxafil is manufactured by Merck & Co. (MSD). Several GMP-certified global pharmaceutical manufacturers also produce generic posaconazole for different markets.

The generic name is posaconazole.

The primary brand name is Noxafil.

Posaconazole is manufactured in Merck’s regulated facilities in the USA and Europe, along with additional GMP-approved manufacturers that supply generic posaconazole for worldwide distribution. 

Related Products

Tioconazole

Strength:
6.5%, 300 mg, 1%

Form: Vaginal Capsule / Vaginal Cream/ topical cream

Reference Brands: Vagistat-1 (USA), Trosyd (EU/LATAM)

View Details
Terconazole

Strength:
0.4%, 0.8%, 80 mg, 120 mg

Form: Cream / Vaginal suppository

Reference Brands: Terazol (USA)

View Details
Tavaborole

Strength:
5%

Form: Topical Solution

Reference Brands: Kerydin (USA/EU)

View Details
Rezafungin Acetate

Strength:
200 mg

Form: Injection

Reference Brands: Rezzayo (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.